GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Bangkok Lab and Cosmetic PCL (BKK:BLC) » Definitions » ROCE %

Bangkok Lab and Cosmetic PCL (BKK:BLC) ROCE % : 14.87% (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Bangkok Lab and Cosmetic PCL ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Bangkok Lab and Cosmetic PCL's annualized ROCE % for the quarter that ended in Dec. 2023 was 14.87%.


Bangkok Lab and Cosmetic PCL ROCE % Historical Data

The historical data trend for Bangkok Lab and Cosmetic PCL's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bangkok Lab and Cosmetic PCL ROCE % Chart

Bangkok Lab and Cosmetic PCL Annual Data
Trend Dec21 Dec22 Dec23
ROCE %
20.76 37.32 17.44

Bangkok Lab and Cosmetic PCL Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROCE % Get a 7-Day Free Trial Premium Member Only 47.75 36.97 13.08 11.72 14.87

Bangkok Lab and Cosmetic PCL ROCE % Calculation

Bangkok Lab and Cosmetic PCL's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=200.231/( ( (1212.623 - 714.855) + (2240.253 - 442.266) )/ 2 )
=200.231/( (497.768+1797.987)/ 2 )
=200.231/1147.8775
=17.44 %

Bangkok Lab and Cosmetic PCL's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=263.512/( ( (2173.161 - 426.156) + (2240.253 - 442.266) )/ 2 )
=263.512/( ( 1747.005 + 1797.987 )/ 2 )
=263.512/1772.496
=14.87 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bangkok Lab and Cosmetic PCL  (BKK:BLC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Bangkok Lab and Cosmetic PCL ROCE % Related Terms

Thank you for viewing the detailed overview of Bangkok Lab and Cosmetic PCL's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bangkok Lab and Cosmetic PCL (BKK:BLC) Business Description

Traded in Other Exchanges
N/A
Address
Nong Chae Sao Road, No. 48/1 Moo 5, Nam Phu, Mueang Ratchaburi, Ratchaburi, Bangkok, THA, 70000
Bangkok Lab and Cosmetic PCL are one of Thailand's comprehensive healthcare solutions groups. Its operation covers the complete value chain of the healthcare business. Its product portfolio comprises generic and new generic drugs, herbal medicines, animal medicines, cosmetics, food supplements, and other health products. Its operation ranges from research and development, manufacturing with international standards, sales, and marketing, to distribution to partnering businesses and customers.

Bangkok Lab and Cosmetic PCL (BKK:BLC) Headlines

No Headlines